155 related articles for article (PubMed ID: 36952047)
1. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
[TBL] [Abstract][Full Text] [Related]
2. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
Şen O; Türkçapar AG; Yerdel MA
J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
[No Abstract] [Full Text] [Related]
3. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Alimoğulları M; Buluş H
Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
9. Association Between Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity.
Hashimoto K; Nagao Y; Nambara S; Tsuda Y; Kudou K; Kusumoto E; Sakaguchi Y; Kusumoto T; Ikejiri K
Obes Surg; 2022 Oct; 32(10):3404-3409. PubMed ID: 36006591
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
[TBL] [Abstract][Full Text] [Related]
11. Management of gallbladder disease after sleeve gastrectomy in a selected Lebanese population.
Dakour Aridi H; Sultanem S; Abtar H; Safadi BY; Fawal H; Alami RS
Surg Obes Relat Dis; 2016 Aug; 12(7):1300-1304. PubMed ID: 27178610
[TBL] [Abstract][Full Text] [Related]
12. Concomitant Cholecystectomy for Asymptomatic Gallstones in Bariatric Surgery-Safety Profile and Feasibility in a Large Tertiary Referral Bariatric Center.
Allatif REA; Mannaerts GHH; Al Afari HST; Hammo AN; Al Blooshi MS; Bekdache OA; Alawadhi O; Isied SH; Hamid S; Shikora SA
Obes Surg; 2022 Feb; 32(2):295-301. PubMed ID: 34791618
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
Nabil TM; Khalil AH; Gamal K
Surg Obes Relat Dis; 2019 Jun; 15(6):827-831. PubMed ID: 31113752
[TBL] [Abstract][Full Text] [Related]
15. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Abdallah E; Emile SH; Elfeki H; Fikry M; Abdelshafy M; Elshobaky A; Elgendy H; Thabet W; Youssef M; Elghadban H; Lotfy A
Surg Today; 2017 Jul; 47(7):844-850. PubMed ID: 27837275
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding.
Moon RC; Teixeira AF; DuCoin C; Varnadore S; Jawad MA
Surg Obes Relat Dis; 2014; 10(1):64-8. PubMed ID: 23932005
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
Mulliri A; Menahem B; Alves A; Dupont B
J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
